Evaluation and review of pharmacoeconomic models.
Difficult decisions as to whether to provide or withhold drug therapy to patients are needed to be made on a daily basis. These decisions should be based on carefully designed and constructed pharmacoeconomic models, with explicit and justifiable parameter values, validated by publication in peer-reviewed literature. This review describes and evaluates the common types of pharmacoeconomic models, modelling approaches and methods. It also discusses model quality, validity and usefulness.
Hay
Joel W
JW
University of Southern California, Department of Pharmaceutical Economics and Policy, CA, USA. JHay@usc.edu
D003362:Cost-Benefit Analysis; D003663:Decision Trees; D017850:Economics, Pharmaceutical; D008390:Markov Chains; D018803:Models, Economic; D009010:Monte Carlo Method; D019057:Quality-Adjusted Life Years; D015203:Reproducibility of Results; D035501:Uncertainty